These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 13191596)

  • 1. [Hematologic modifications during triethylenemelamine therapy].
    LENTI G; GAVOSTO F
    G Ital Chemioter; 1954; 1(1):105-7. PubMed ID: 13191596
    [No Abstract]   [Full Text] [Related]  

  • 2. [The hematologic modifications induced by largactil].
    RIZZO EM; RUSSO S
    Rass Studi Psichiatr; 1953; 42(4):632-40. PubMed ID: 13134568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic action of intravenous TEM].
    TURCO GL; LOVISETTO P
    Minerva Med; 1955 Feb; 46(13):402-15. PubMed ID: 14355902
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with triethylene melamine (TEM) and triethylene thiophosphoramide (thioTEPA) in recurrent or metastatic solid tumors.
    SCHELL RF; HALL BE
    Surg Gynecol Obstet; 1958 Apr; 106(4):459-65. PubMed ID: 13529522
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
    Bhalla KN
    J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of synestrol on modifications in the peripheral blood in white mice].
    ZAK KP
    Med Zhurnal; 1953; 23(5):28-35. PubMed ID: 13132431
    [No Abstract]   [Full Text] [Related]  

  • 7. The hematologic response to adrenalin.
    GROISSER VW; RUBERMAN W
    J Lab Clin Med; 1954 Mar; 43(3):386-94. PubMed ID: 13143326
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematologic aspects of drug toxicity.
    STOHLMAN F
    N Y State J Med; 1954 Dec; 54(24):3421-4. PubMed ID: 13214463
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of mixed and exclusive nutrition with byproducts of the citrus fruit industry on blood constituents in goats. I. Influence on the hematologic picture].
    ZANNELLI C
    Boll Soc Ital Biol Sper; 1958 Jan; 34(2):44-8. PubMed ID: 13522951
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research on the biological activity of cycloserine. I. Action on the peripheral hematologic picture; preliminary note].
    TRIPODO C
    Boll Soc Ital Biol Sper; 1958 Jan; 34(2):57-9. PubMed ID: 13522956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of isonicotinic acid hydrazide on the hematologic picture and on hepatic and renal function tests].
    MENDOZA EUWING C
    An Fac Med Lima; 1953; 36(4):487-520. PubMed ID: 13207755
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hematologic, modifications in stomach cancer; study of 450 cases].
    GELBAND J; FABRE J; DELLA SANTA R
    Helv Med Acta; 1955 May; 22(2):156-66. PubMed ID: 14391819
    [No Abstract]   [Full Text] [Related]  

  • 13. [The study of hematochemical modifications in subjects treated with phenylbutazone].
    GAGLIO M
    Reumatismo; 1954; 6(2 Suppl.):32-4. PubMed ID: 13178020
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood cell modifications after injection in rabbits].
    ARDOINO AL
    Rev Hematol; 1958; 13(3):311-9. PubMed ID: 13591883
    [No Abstract]   [Full Text] [Related]  

  • 15. [The present & future in the therapy of hemoblastosis].
    DI GUGLIELMO G
    Riforma Med; 1957 Dec; 71(49):1381-3. PubMed ID: 13528572
    [No Abstract]   [Full Text] [Related]  

  • 16. Triethylenemelamine and its associations in the treatment of hemolymphoblastoses and other neoplasms.
    MARMONT A; FUSCO F
    G Ital Chemioter; 1954; 1(1):193-5. PubMed ID: 13191624
    [No Abstract]   [Full Text] [Related]  

  • 17. The unique place of folic acid antagonists in controlling malignant blood diseases.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1960 Nov; 132():415-20. PubMed ID: 13745965
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematopoietic stem cell transplant as a platform for tumor immunotherapy.
    Fuchs EJ; Whartenby KA
    Curr Opin Mol Ther; 2004 Feb; 6(1):48-53. PubMed ID: 15011781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of some biochemical constants during triethylenemelamine therapy].
    BUFFA F; VERGNANO F; RESEGOTTI L; SARTORIS S
    G Ital Chemioter; 1954; 1(1):109-11. PubMed ID: 13191599
    [No Abstract]   [Full Text] [Related]  

  • 20. Histone modifications as a platform for cancer therapy.
    Espino PS; Drobic B; Dunn KL; Davie JR
    J Cell Biochem; 2005 Apr; 94(6):1088-102. PubMed ID: 15723344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.